Please Wait

Applying Filters...

Drug Product Composition: PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 4 USDMF, 6 CEP/COS, 1 JDMF, 3 EU WC, 2 KDMF, 12 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

110 FDF Dossiers, 30 FDA Orange Book, 48 Europe, 31 Canada, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.25%;0.0091MG/ML, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 0.25%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - 0.75%, INJECTABLE;INJECTION - 0.75%;0.0091MG/ML, INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML), INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML), INJECTABLE;INJECTION - 0.5%;0.0091MG/ML, INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%, INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Actylis

4 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

36 Finished Drug Prices

36 Finished Drug Prices

MARKET PLACE

25 APIs, 3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM, 1 USP, 2 JP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 16964 / DOSAGE - INJECTABLE;INJECTION - 0.75%

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
Bupivacaine Hydrochloride(UNII: 7TQO7W3VT8) (Bupivacaine - UNII:Y8335394RO)	Bupivacaine Hydrochloride	5mg in 1

Drug Product Composition: PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

PRILOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers

4 USDMF

6 CEP/COS

1 JDMF

3 EU WC

2 KDMF

12 NDC API

13 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

1 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

110 FDF Dossiers

30 FDA Orange Book

48 Europe

31 Canada

1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.25%;0.0091MG/ML

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 0.25%

INJECTABLE;INJECTION - 0.5%

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - 0.75%

INJECTABLE;INJECTION - 0.75%;0.0091MG/ML

INJECTABLE;INJECTION - 4%; EQ 0.0085MG BASE/1.7ML (4%; EQ 0.005MG BASE/ML)

INJECTABLE;INJECTION - 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML)

INJECTABLE;INJECTION - 0.5%;0.0091MG/ML

INJECTABLE;INJECTION - EQ 0.02MG BASE/ML;2%

INJECTABLE;INJECTION - EQ 0.01MG BASE/ML;2%

RELATED EXCIPIENT COMPANIES

4 Actylis

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

9 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

36 Finished Drug Prices

MARKET PLACE

25 APIs

3 FDF Dossiers

REF. STANDARDS & IMPURITIES

6 EDQM

1 USP

2 JP

1 Others

Filters